These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 9831198
21. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes. Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS. Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517 [Abstract] [Full Text] [Related]
22. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P. Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183 [Abstract] [Full Text] [Related]
23. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study. Raju U, Ma CK, Shaw A. Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106 [Abstract] [Full Text] [Related]
24. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. Ko YH, Roh JH, Son YI, Chung MK, Jang JY, Byun H, Baek CH, Jeong HS. J Oral Pathol Med; 2010 Apr; 39(4):349-55. PubMed ID: 20040022 [Abstract] [Full Text] [Related]
25. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, Sneige N, Sahin A, Gilcrease MZ. Clin Cancer Res; 2005 May 01; 11(9):3309-14. PubMed ID: 15867228 [Abstract] [Full Text] [Related]
26. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Nguyen VN, Mirejovský T, Melinová L, Mandys V. Neoplasma; 2000 May 01; 47(6):400-8. PubMed ID: 11263866 [Abstract] [Full Text] [Related]
27. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance. Xu B, Dogan S, Haroon Al Rasheed MR, Ghossein R, Katabi N. Hum Pathol; 2019 Nov 01; 93():30-36. PubMed ID: 31430492 [Abstract] [Full Text] [Related]
28. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T. Cancer; 2005 Jun 15; 103(12):2526-33. PubMed ID: 15900577 [Abstract] [Full Text] [Related]
29. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Vadlamudi RK, Balasenthil S, Sahin AA, Kies M, Weber RS, Kumar R, El-Naggar AK. Hum Pathol; 2005 Jun 15; 36(6):670-5. PubMed ID: 16021574 [Abstract] [Full Text] [Related]